Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/14/9/1430/644132/mdg374.pdf
Reference30 articles.
1. Doxil Clinical Series;Dezube,1996
2. Liposomal encapsulated anthracyclines: new therapeutic horizons;Muggia;Curr Oncol Rep,2001
3. Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma;Lyass;Cancer,2000
4. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy;Gabizon;Cancer Invest,2001
5. Phase I study of Doxil–cisplatin combination chemotherapy in patients with advanced malignancies;Lyass;Clin Cancer Res,2001
Cited by 396 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice;Molecular Pharmaceutics;2024-01-25
2. mRNA-LNP COVID-19 vaccine lipids induce low level complement activation and production of proinflammatory cytokines: Mechanisms, effects of complement inhibitors, and relevance to adverse reactions;2024-01-15
3. Scope of Biological Property Activated Plant Extracted Nanoparticles for Human Immune Response — A Review;Nano LIFE;2024-01-05
4. In Vitro and Preclinical Antitumor Evaluation of Doxorubicin Liposomes Coated with a Cholesterol-Based Trimeric β-D-Glucopyranosyltriazole;Pharmaceutics;2023-12-11
5. Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery;Advanced Drug Delivery Reviews;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3